Estrella Immunopharma Quote - ESLA

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.11

Bid

1.11

Offer

1.17

Volume

5,447

1.1065 Day's Range 1.18

0.63 52 Week Range 3.23

Market Cap

40.159M

Previous Close

1.17

Open

1.18

Last Trade

1.13

Last Trade Time

Financial Volume

US$ 6,107

VWAP

1.1211

Average Volume (3m)

30,883

Shares Outstanding

36,179,147

Dividend Yield

PE Ratio

-5.49

Earnings Per Share (EPS)

-0.2

Revenue

Net Profit

-7.31M

TradeUP Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. TradeUP Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Headquarters

Wilmington, Delaware, USA

Founded

Estrella Immunopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ESLA. The last closing price for Estrella Immunopharma was US$1.17. Over the last year, Estrella Immunopharma shares have traded in a share price range of US$ 0.63 to US$ 3.23.

Estrella Immunopharma currently has 36,179,147 shares in issue. The market capitalisation of Estrella Immunopharma is US$42.33 million. Estrella Immunopharma has a price to earnings ratio (PE ratio) of -5.49.

Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) (“Estrella” or the “Company”), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat...

Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) ("Estrella", “Estrella Immunopharma”, or the "Company"), a clinical stage biopharmaceutical company focused on developing CD19 and CD22-targeted...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.09	-7.5	1.2	1.2	1.06	8277	1.14160575	CS
4	-0.18	-13.9534883721	1.29	1.3165	1.02	13006	1.17976113	CS
12	0.2591	30.4501116465	0.8509	1.485	0.695101	30883	1.19635999	CS
26	-1.16	-51.1013215859	2.27	2.55	0.63	84471	1.20290052	CS
52	-0.11	-9.01639344262	1.22	3.23	0.63	70559	1.42066705	CS
156	-4.1	-78.6948176583	5.21	5.62	0.63	73776	1.55420976	CS
260	-4.1	-78.6948176583	5.21	5.62	0.63	73776	1.55420976	CS

ESLA - Frequently Asked Questions (FAQ)

What is the current Estrella Immunopharma share price?

The current share price of Estrella Immunopharma is US$ 1.11

How many Estrella Immunopharma shares are in issue?

Estrella Immunopharma has 36,179,147 shares in issue

What is the market cap of Estrella Immunopharma?

The market capitalisation of Estrella Immunopharma is USD 42.33M

What is the 1 year trading range for Estrella Immunopharma share price?

Estrella Immunopharma has traded in the range of US$ 0.63 to US$ 3.23 during the past year

What is the PE ratio of Estrella Immunopharma?

The price to earnings ratio of Estrella Immunopharma is -5.49

What is the reporting currency for Estrella Immunopharma?

Estrella Immunopharma reports financial results in USD

What is the latest annual profit for Estrella Immunopharma?

The latest annual profit of Estrella Immunopharma is USD -7.31M

What is the registered address of Estrella Immunopharma?

The registered address for Estrella Immunopharma is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801

Which industry sector does Estrella Immunopharma operate in?

Estrella Immunopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SLXNSilexion Therapeutics Corporation	US$ 1.335 (130.17%)	237.58M
TRIBTrinity Biotech PLC	US$ 1.36 (78.95%)	116.26M
YIBOPlanet Image International Ltd	US$ 5.10 (65.58%)	55.21M
DGNXDiginex Ltd	US$ 15.42 (63.69%)	1.74M
HAOHaoxi Health Technology Ltd	US$ 3.70 (47.41%)	2.81M
LPTXLeap Therapeutics Inc	US$ 0.64 (-71.56%)	12.88M
STSSSharps Technology Inc	US$ 0.4516 (-69.07%)	20.96M
SABSSAB Biotherapeutics Inc	US$ 2.07 (-52.52%)	1.56M
MGOLMGO Global Inc	US$ 0.1648 (-41.77%)	38.41M
TECXTectonic Therapeutic Inc	US$ 24.36 (-40.85%)	1.18M
NVDANVIDIA Corporation	US$ 128.99 (8.93%)	567.34M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.46005 (11.64%)	381.45M
HEPAHepion Pharmaceuticals Inc	US$ 0.2192 (32.85%)	314.78M
SLXNSilexion Therapeutics Corporation	US$ 1.335 (130.17%)	237.58M
JBLUJetBlue Airways Corporation	US$ 6.01 (-25.71%)	124.57M